| 注册
首页|期刊导航|老年医学与保健|SARC-F筛查肌少症效能的优化研究

SARC-F筛查肌少症效能的优化研究

刘陪沛 王芳 曹梦宇 徐率轩 张倪惠 刘金炜 陈超 彭楠

老年医学与保健2024,Vol.30Issue(4):930-934,952,6.
老年医学与保健2024,Vol.30Issue(4):930-934,952,6.

SARC-F筛查肌少症效能的优化研究

A study on optimization of SARC-F screening efficacy for sarcopenia

刘陪沛 1王芳 2曹梦宇 2徐率轩 2张倪惠 2刘金炜 3陈超 3彭楠2

作者信息

  • 1. 中央军委机关事务管理总局,北京 100034
  • 2. 中国人民解放军总医院第二医学中心康复医学科,国家老年疾病临床医学研究中心,北京 100853
  • 3. 解放军医学院研究生院,北京 100853
  • 折叠

摘要

Abstract

Objective To explore an optimization method of SARC-F screening efficacy for sarcopenia.Methods From March 2018 to August 2021,the SARC-F scoring scale,Asian Working Group for Sarcopenia 2(AWGS2)and European Working Group on Sarcopenia in Older People 2(EWGSOP2)were used to diagnose sarcopenia in the subjects.Results The prevalence of sarcopenia diagnosed by SARC-F,AWGS2 and EWGSOP2 were 12.78%(52/407),28.26%(115/407)and 31.20%(127/407),respectively.Taking AWGS2 and EWGSOP2 as the gold criteria,the sensitivity of SARC-F ≥4 for screening sarcopenia was 37.39%(43/115)and 35.43%(45/127),and the specificity was 96.92%(283/292)and 97.50%(273/280).Receiver operator characteristic curve showed that the optimal cut-off value of SARC-F was 2 points.The sensitiv-ity of SARC-F≥ 2 for screening sarcopenia was 89.57%(103/115)and 88.98%(113/127),and the specificity was 76.71%(224/292)and 79.29%(222/280).Conclusion SARC-F≥2 may have higher sensitivity for diagnosing sarcopenia and is more suitable for initial screening.

关键词

老年人/肌少症/诊断标准/患病率

Key words

elderly/sarcopenia/diagnostic criteria/prevalence

引用本文复制引用

刘陪沛,王芳,曹梦宇,徐率轩,张倪惠,刘金炜,陈超,彭楠..SARC-F筛查肌少症效能的优化研究[J].老年医学与保健,2024,30(4):930-934,952,6.

基金项目

国家重点研发计划(2018YFC2002004) (2018YFC2002004)

老年医学与保健

OACSTPCD

1008-8296

访问量4
|
下载量0
段落导航相关论文